Kaifeng Darui Pharmaceutical Co., Ltd. | Interactive Overview

Driving Innovation in Pharmaceutical Excellence

As a leading GMP-certified manufacturer of high-end pharmaceutical raw materials and veterinary APIs, we are your trusted partner for quality, sustainability, and innovation in a global market.

Explore Our Core Values

Our Foundational Pillars

We build our success on three core principles. Click to explore how each pillar defines our commitment to excellence.

GMP Certified Excellence

Quality is the cornerstone of everything we do. As a GMP-certified company, we adhere to the most stringent international standards. Our state-of-the-art facilities include Grade D cleanroom-certified API workshops, ensuring a controlled and contaminant-free environment for every stage of production.

This unwavering commitment guarantees that every batch of our pharmaceutical raw materials and veterinary APIs meets the highest purity, efficacy, and safety standards.

Our Quality Control Process

1
Raw Material Sourcing & Testing
2
Controlled API Production
3
In-Process & Final QC Checks
Batch Release & Certification

Why Partner With Kaifeng Darui?

We provide more than just ingredients; we provide a foundation for your success. Here’s the value we bring to every partnership.

Uncompromising Quality

Adherence to the highest GMP standards for guaranteed purity and efficacy.

Sustainable Practices

Environmentally responsible manufacturing for a greener future.

Reliable Supply Chain

Consistent and timely production of high-end APIs and raw materials.

Global Reach

Serving and supporting pharmaceutical manufacturers worldwide.

Innovative Solutions

Continuously developing advanced pharmaceutical ingredients.

Cost-Quality Advantage

Access to premium animal health and pharmaceutical solutions.

Let's Build a Healthier Future Together

For inquiries about our capabilities or to discuss potential collaborations, please reach out. We are ready to be your trusted partner.

Contact Us

© 2025 Kaifeng Darui Pharmaceutical Co., Ltd. All Rights Reserved.

Breakthrough in Energetic Materials: Novel Non-Metallic Pentazolate Salts with Cage-Like Cations

In the quest for next-generation high-energy-density materials (HEDMs), researchers have long sought to harness the explosive potential of nitrogen-rich compounds. Among these, the pentazolate anion (cyclo-N₅⁻)—a stable, aromatic five-membered nitrogen ring—has emerged as a star candidate. However, the practical application of pentazolates has been hindered by the presence of non-energetic metal cations or crystallization water in their structures.

A recent study by Jiang Tianyu and colleagues from the China Academy of Engineering Physics introduces two groundbreaking non-metallic pentazolate salts that address these limitations. Their work, published in Chinese Journal of Energetic Materials, details the synthesis and characterization of Methenamine pentazolate (C₆H₁₃N₉) and methylated Methenamine pentazolate (C₇H₁₅N₉)—materials that combine high energy output with improved stability. Let’s dive into the science behind these innovations.


Why Cage-Like Cations Matter

Traditional pentazolate salts often rely on metal ions (e.g., Na⁺, Ag⁺) or hydrate structures, which dilute energy density and complicate crystallization. Methenamine (hexamethylenetetramine), a nitrogen-rich organic compound with a unique cage-like structure, offers a compelling alternative. Its rigid framework and high nitrogen content (43% by mass) make it ideal for stabilizing the reactive cyclo-N₅⁻ anion while boosting energetic performance.


Synthesis and Structural Insights

The team synthesized the two salts via ion exchange:

  1. Methenamine pentazolate (1): Reacting Methenamine hydrochloride with AgN₅ in water yielded anhydrous crystals after filtration and evaporation.
  2. Methylated Methenamine pentazolate (2): A similar process using methylated Methenamine iodide produced the methyl-derivative.

Single-crystal X-ray diffraction revealed:

  • Compound 1 crystallizes in a monoclinic system (P2₁/c) with a density of 1.448 g·cm⁻³, forming a hydrogen-bonded network where cyclo-N₅⁻ anions nest within Methenamine’s cage-like cavities (Figure 1a).
  • Compound 2 adopts a simpler monoclinic lattice (P2₁/m) with lower density (1.389 g·cm⁻³), where methyl groups slightly distort the cation-anion interactions.

Notably, cyclo-N₅⁻ in 1 exhibited near-perfect planarity (HOMA = 0.98–0.99), while 2 showed minor distortions (HOMA = 0.74), hinting at reduced stability.


Thermal Stability: A Critical Advantage

Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) highlighted key differences:

  • Compound 1: Decomposed at 90.0°C (onset) with a sharp exotherm, followed by a two-stage mass loss linked to N₅⁻ breakdown and subsequent reactions.
  • Compound 2: Less stable, decomposing at 82.8°C with a three-stage mass loss, likely due to weaker cation-anion interactions.

The superior thermal resilience of 1 aligns with its stronger hydrogen-bonding network and aromatic N₅⁻ ring—a critical factor for safe handling and storage.


Energetic Performance: Blowing Past Predecessors

Using EXPLO5 software, the team calculated detonation properties:

  • Compound 1Detonation velocity (D) = 8,291 m·s⁻¹pressure (p) = 20.33 GPa.
  • Compound 2D = 7,862 m·s⁻¹p = 17.41 GPa.

These values surpass earlier cage-cation pentazolates (e.g., hydrate-containing salts with D ≈ 6,700–7,800 m·s⁻¹), thanks to the anhydrous structure and high nitrogen content of Methenamine.


Safety First: Sensitivity Matters

While energy density is crucial, sensitivity determines practicality. BAM tests showed:

  • Impact Sensitivity1 (5 J) > 2 (3 J).
  • Friction Sensitivity1 (288 N) > 2 (86 N).

Compound 1’s lower sensitivity—despite higher energy—stems from its robust hydrogen-bonding network and higher HOMO-LUMO gap (5.64 eV vs. 4.79 eV for 2), which reduces reactivity to external stimuli.


Why This Work Stands Out

  1. Non-Metallic Innovation: Replacing metal cations with nitrogen-rich Methenamine eliminates dead weight, boosting energy density.
  2. Anhydrous Design: Avoiding crystallization water improves thermal stability and detonation performance.
  3. Tunable Properties: Methylation in 2 demonstrates how minor structural tweaks can balance energy and sensitivity.

Future Directions

The authors suggest exploring larger cage-like cations or co-crystallization strategies to further optimize stability and performance. Such advances could pave the way for practical applications in propellants, explosives, or even green pyrotechnics.


Final Thoughts

Jiang Tianyu’s work exemplifies how clever molecular design can unlock the potential of nitrogen-rich chemistry. By marrying the unique geometry of Methenamine with the explosive power of cyclo-N₅⁻, this study opens new avenues for safer, more powerful HEDMs—a win for both science and safety.

Summary of the Study:​

This study reports the synthesis and comprehensive characterization of two novel pentazolate salts based on methenamine (urotropine) cage-like cations: ​urotropine pentazolate (C₆H₁₃N₉, 1)​​ and ​methylated urotropine pentazolate (C₇H₁₅N₉, 2)​. The research focuses on their structural features, thermal stability, energetic performance, and sensitivity, aiming to advance the development of high-energy-density materials (HEDMs) with non-metallic cations.


Key Findings:​

1. Synthesis and Structural Characterization

  • Synthesis Route:
    • Compound ​1​ was synthesized via ion exchange between urotropine hydrochloride and silver pentazolate (AgN₅).
    • Compound ​2​ was derived from methylated urotropine iodide and AgN₅.
    • Both salts were crystallized from aqueous solutions, yielding single crystals for X-ray diffraction analysis.
  • Crystal Structures:
    • Compound 1​ crystallizes in the monoclinic system (space group P2₁/c) with cell parameters:
      a = 13.6795(2) Å, b = 11.6892(1) Å, c = 12.5941(2) Å, β = 105.822(1)°, Z = 8, Dc = 1.448 g·cm⁻³.
    • Compound 2​ adopts a monoclinic lattice (space group P2₁/m) with parameters:
      a = 6.9025(5) Å, b = 7.6042(5) Å, c = 10.6808(9) Å, β = 106.148(8)°, Z = 2, Dc = 1.389 g·cm⁻³.
    • The cyclo-N₅⁻ anions in ​1​ exhibit planar geometries with high aromaticity (HOMA = 0.98–0.99), while ​2​ shows slightly distorted N₅⁻ rings (HOMA = 0.74), indicating reduced stability.
    • Both structures feature cage-like cations forming confined spaces that stabilize N₅⁻ via hydrogen bonding and electrostatic interactions (Figure 1).

2. Weak Interactions and Stability

  • Hirshfeld Surface Analysis:
    • N···H interactions dominate (61.8% for ​1, 58.7% for ​2), confirming hydrogen bonding as the primary stabilizing force.
    • IRI Analysis: Compound ​1​ exhibits stronger intermolecular interactions (average binding energy Ēbind = 154.82 kJ·mol⁻¹) compared to ​2​ (Ēbind = 140.25 kJ·mol⁻¹), aligning with its superior thermal stability.

3. Thermal Behavior

  • TG-DSC Results:
    • Compound 1: Decomposes at ​90.0°C​ (onset) with a two-stage mass loss (40% and 57%), attributed to N₅⁻ decomposition and subsequent reactions.
    • Compound 2: Lower decomposition temperature (82.8°C) and a three-stage mass loss (12%, 75%), reflecting weaker stabilization of N₅⁻.

4. Energetic Performance

  • Detonation Properties​ (Calculated via EXPLO5):
    • Compound 1: Detonation velocity (D) = 8,291 m·s⁻¹, pressure (p) = 20.33 GPa.
    • Compound 2D = 7,862 m·s⁻¹, p = 17.41 GPa.
    • Both outperform earlier cage-cation pentazolates (e.g., ​3​ and ​4​ with D = 6,751–7,816 m·s⁻¹), attributed to higher nitrogen content and optimized crystal packing.
  • Sensitivity Tests:
    • Impact Sensitivity: ​1​ (5 J) > ​2​ (3 J).
    • Friction Sensitivity: ​1​ (288 N) > ​2​ (86 N).
    • 1​ demonstrates lower sensitivity despite higher energy, linked to stronger hydrogen bonding and higher HOMO-LUMO gap (5.64 eV vs. ​2: 4.79 eV).

Conclusions

  • Structural Innovation: Urotropine-based cations enable crystallization of anhydrous pentazolates, avoiding performance-limiting crystallization water.
  • Performance Enhancement: The high nitrogen content of urotropine cations improves detonation performance over prior systems.
  • Stability-Sensitivity Tradeoff: Methylation in ​2​ reduces thermal stability and increases sensitivity, highlighting the critical role of hydrogen bonding and aromaticity in cyclo-N₅⁻ stabilization.

This work advances the design of non-metallic pentazolate salts with tailored energetic properties, offering insights into optimizing stability and performance for practical applications in propellants and explosives.

Key Terms: Cyclo-N₅⁻, methenamine, cage-like cations, non-metallic salts, detonation performance, thermal stability.

Rifamycin O (CAS No. 14487-05-9)

1. What Is Rifamycin O? Rifamycin O is a semi-synthetic antibiotic belonging to the rifamycin group, with a molecular formula of C₄₈H₆₈N₄O₁...

My Instagram